(Q33800977)

29 July 2017

1 reference

title

Taxanes: an overview of the pharmacokinetics and pharmacodynamics (English)

1 reference

29 July 2017

1 reference

1 reference

U Vaishampayan

1

1 reference

29 July 2017

R E Parchment

series ordinal

2

1 reference

29 July 2017

B R Jasti

series ordinal

3

1 reference

29 July 2017

M Hussain

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

29 July 2017

1 reference

29 July 2017

54

1 reference

29 July 2017

22-29

1 reference

29 July 2017

6A Suppl

1 reference

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Promotion of microtubule assembly in vitro by taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

The taxoids. Comparative clinical pharmacology and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

The taxoids: paclitaxel and docetaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Tubulin alterations in taxol-induced apoptosis parallel those observed with other drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Inactivation of Bcl-2 by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Clinical pharmacokinetics of paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Taxanes: a new class of antitumor agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Paclitaxel in advanced urothelial carcinoma: its role in patients with renal insufficiency and as salvage therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Sequences of taxol and cisplatin: a phase I and pharmacologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

Phase I and pharmacologic study of sequences of paclitaxel and cyclophosphamide supported by granulocyte colony-stimulating factor in women with previously treated metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900451-3

7 January 2021

10.1016/S0090-4295(99)00451-3

Identifiers

DOI

1 reference

29 July 2017

1 reference